Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ·Healthcare·Biotechnology
$11.75
+0.73%
Mkt Cap $925.17M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (16 analysts)
$24.67
Range $18.00 – $28.00
Implied Upside
+110.0%
Consensus $24.67 vs current $11.75
NASDAQ·Healthcare·Biotechnology
$11.75
+0.73%
Mkt Cap $925.17M
Buy
3
Hold
0
Sell
0
Price Target (16 analysts)
$24.67
Range $18.00 – $28.00
+110.0%
Consensus $24.67 vs current $11.75